Bestzyme’s Mellia™ Brazzein Receives FDA “No Questions” Letter, Bringing Creative Sugar Reduction Solution to Global Market

PISCATAWAY, N.J., April 26, 2025 /PRNewswire/ — Bestzyme is pleased to announce a flagship product Mellia™ Brazzein, has officially received the “No Questions” letter from the U.S. Food and Drug Administration (FDA) regarding its GRAS (Generally Recognized as Safe) status. The GRAS…